Faculty Opinions recommendation of Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps.

Author(s):  
Gary Bader ◽  
Mohamed Helmy
Oncogenesis ◽  
2015 ◽  
Vol 4 (7) ◽  
pp. e160-e160 ◽  
Author(s):  
I Kuperstein ◽  
E Bonnet ◽  
H-A Nguyen ◽  
D Cohen ◽  
E Viara ◽  
...  

2018 ◽  
Vol 80 ◽  
pp. 19-20
Author(s):  
Thayne W. Kowalski ◽  
Lucas R. Fraga ◽  
Mariana Recamonde-Mendoza ◽  
Julia A. Gomes ◽  
Lavínia Schüler-Faccini ◽  
...  

2020 ◽  
Vol 36 (8) ◽  
pp. 2620-2622 ◽  
Author(s):  
Irina Balaur ◽  
Ludovic Roy ◽  
Alexander Mazein ◽  
S Gökberk Karaca ◽  
Ugur Dogrusoz ◽  
...  

Abstract Motivation CellDesigner is a well-established biological map editor used in many large-scale scientific efforts. However, the interoperability between the Systems Biology Graphical Notation (SBGN) Markup Language (SBGN-ML) and the CellDesigner’s proprietary Systems Biology Markup Language (SBML) extension formats remains a challenge due to the proprietary extensions used in CellDesigner files. Results We introduce a library named cd2sbgnml and an associated web service for bidirectional conversion between CellDesigner’s proprietary SBML extension and SBGN-ML formats. We discuss the functionality of the cd2sbgnml converter, which was successfully used for the translation of comprehensive large-scale diagrams such as the RECON Human Metabolic network and the complete Atlas of Cancer Signalling Network, from the CellDesigner file format into SBGN-ML. Availability and implementation The cd2sbgnml conversion library and the web service were developed in Java, and distributed under the GNU Lesser General Public License v3.0. The sources along with a set of examples are available on GitHub (https://github.com/sbgn/cd2sbgnml and https://github.com/sbgn/cd2sbgnml-webservice, respectively). Supplementary information Supplementary data are available at Bioinformatics online.


2011 ◽  
Vol 3 (4) ◽  
pp. 561-568 ◽  
Author(s):  
Lei Zhu ◽  
Amit Bhattacharyya ◽  
Edit Kurali ◽  
Amber Anderson ◽  
Alan Menius ◽  
...  

2012 ◽  
Vol 51 (02) ◽  
pp. 152-161 ◽  
Author(s):  
J. Huang ◽  
Y. Xie ◽  
N. Yi ◽  
S. Ma

SummaryObjectives: In breast cancer research, it is important to identify genomic markers associated with prognosis. Multiple microarray gene expression profiling studies have been conducted, searching for prognosis markers. Genomic markers identified from the analysis of single datasets often suffer a lack of reproducibility because of small sample sizes. Integrative analysis of data from multiple independent studies has a larger sample size and may provide a cost-effective solution.Methods: We collect four breast cancer prognosis studies with gene expression measurements. An accelerated failure time (AFT) model with an unknown error distribution is adopted to describe survival. An integrative sparse boosting approach is employed for marker selection. The proposed model and boosting approach can effectively accommodate heterogeneity across multiple studies and identify genes with consistent effects.Results: Simulation study shows that the proposed approach outperforms alternatives including meta-analysis and intensity approaches by identifying the majority or all of the true positives, while having a low false positive rate. In the analysis of breast cancer data, 44 genes are identified as associated with prognosis. Many of the identified genes have been previously suggested as associated with tumorigenesis and cancer prognosis. The identified genes and corresponding predicted risk scores differ from those using alternative approaches. Monte Carlo-based prediction evaluation suggests that the proposed approach has the best prediction performance.Conclusions: Integrative analysis may provide an effective way of identifying breast cancer prognosis markers. Markers identified using the integrative sparse boosting analysis have sound biological implications and satisfactory prediction performance.


2009 ◽  
Vol 151 (4) ◽  
pp. 1758-1768 ◽  
Author(s):  
Je-Gun Joung ◽  
Anthony M. Corbett ◽  
Shanna Moore Fellman ◽  
Denise M. Tieman ◽  
Harry J. Klee ◽  
...  

2018 ◽  
Vol 11 (S2) ◽  
Author(s):  
Seonggyun Han ◽  
Dongwook Kim ◽  
Youngjun Kim ◽  
Kanghoon Choi ◽  
Jason E. Miller ◽  
...  

2021 ◽  
Author(s):  
Mahnoor Naseer Gondal ◽  
Safee Ullah Chaudhary

Rapid advancements in high-throughput omics technologies and experimental protocols have led to the generation of vast amounts of biomolecular data on cancer that now populates several online databases and resources. Cancer systems biology models built on top of this data have the potential to provide specific insights into complex multifactorial aberrations underpinning tumor initiation, development, and metastasis. Furthermore, the annotation of these single- or multi-scale models with patient data can additionally assist in designing personalized therapeutic interventions as well as aid in clinical decision-making. Here, we have systematically reviewed the emergence and evolution of (i) repositories with scale-specific and multiscale biomolecular cancer data, (ii) systems biology models developed using this data, (iii) associated simulation software for development of personalized cancer therapeutics, and (iv) translational attempts to pipeline multi-scale panomics data for data-driven in silico clinical oncology. The review concludes by highlighting that the absence of a generic, zero-code, panomics-based multi-scale modeling pipeline and associated software framework, impedes the development and seamless deployment of personalized in silico multi-scale models in clinical settings.


Sign in / Sign up

Export Citation Format

Share Document